168 related articles for article (PubMed ID: 19815174)
1. Funneling: enhancing results of small-vessel stenting.
Kaluski E; Gerula C; Randhawa P; Klapholz M
Cardiovasc Revasc Med; 2009; 10(4):255-8. PubMed ID: 19815174
[TBL] [Abstract][Full Text] [Related]
2. Outcomes with drug-eluting versus bare-metal stents in saphenous vein graft intervention results from the STENT (strategic transcatheter evaluation of new therapies) group.
Brodie BR; Wilson H; Stuckey T; Nussbaum M; Laurent S; Bradshaw B; Humphrey A; Metzger C; Hermiller J; Krainin F; Juk S; Cheek B; Duffy P; Simonton CA;
JACC Cardiovasc Interv; 2009 Nov; 2(11):1105-12. PubMed ID: 19926052
[TBL] [Abstract][Full Text] [Related]
3. Clinical presentation and angiographic characteristics of saphenous vein graft failure after stenting: insights from the SOS (stenting of saphenous vein grafts) trial.
Lichtenwalter C; de Lemos JA; Roesle M; Obel O; Holper EM; Haagen D; Saeed B; Iturbe JM; Shunk K; Bissett JK; Sachdeva R; Voudris VV; Karyofillis P; Kar B; Rossen J; Fasseas P; Berger P; Banerjee S; Brilakis ES
JACC Cardiovasc Interv; 2009 Sep; 2(9):855-60. PubMed ID: 19778774
[TBL] [Abstract][Full Text] [Related]
4. Long-term outcomes of drug-eluting stents versus bare-metal stents in saphenous vein graft disease: results from the Prairie "Real World" Stent Registry.
Goswami NJ; Gaffigan M; Berrio G; Plessa AL; Pfeiffer AM; Markwell SJ; Mishkel GJ
Catheter Cardiovasc Interv; 2010 Jan; 75(1):93-100. PubMed ID: 19787803
[TBL] [Abstract][Full Text] [Related]
5. A multicenter randomized comparison of paclitaxel-coated balloon catheter with conventional balloon angioplasty in patients with bare-metal stent restenosis and drug-eluting stent restenosis.
Habara S; Iwabuchi M; Inoue N; Nakamura S; Asano R; Nanto S; Hayashi Y; Shiode N; Saito S; Ikari Y; Kimura T; Hosokawa J; Nakamura M; Kotani J; Kozuma K; Mitsudo K
Am Heart J; 2013 Sep; 166(3):527-33. PubMed ID: 24016503
[TBL] [Abstract][Full Text] [Related]
6. Paclitaxel-coated balloon with bare-metal stenting in patients with chronic total occlusions in native coronary arteries.
Wöhrle J; Werner GS
Catheter Cardiovasc Interv; 2013 Apr; 81(5):793-9. PubMed ID: 22511572
[TBL] [Abstract][Full Text] [Related]
7. Comparison of percutaneous coronary intervention with bare-metal and drug-eluting stents for cardiac allograft vasculopathy.
Lee MS; Kobashigawa J; Tobis J
JACC Cardiovasc Interv; 2008 Dec; 1(6):710-5. PubMed ID: 19463388
[TBL] [Abstract][Full Text] [Related]
8. 3-year clinical outcome of patients with chronic total occlusion treated with drug-eluting stents.
De Felice F; Fiorilli R; Parma A; Nazzaro M; Musto C; Sbraga F; Caferri G; Violini R
JACC Cardiovasc Interv; 2009 Dec; 2(12):1260-5. PubMed ID: 20129553
[TBL] [Abstract][Full Text] [Related]
9. The effect of stent coating on stent deliverability: direct randomised comparison of drug eluting and bare metal stents using the same stent platform.
Siminiak T; Link R; Wołoszyn M; Kałmucki P; Baszko A
Kardiol Pol; 2012; 70(10):998-1002. PubMed ID: 23080088
[TBL] [Abstract][Full Text] [Related]
10. Clinical presentation and outcome of patients hospitalized for symptomatic in-stent restenosis treated by percutaneous coronary intervention: comparison between drug-eluting stents and bare-metal stents.
De Labriolle A; Bonello L; Lemesle G; Steinberg DH; Roy P; Xue Z; Kaneshige K; Suddath WO; Satler LF; Kent KM; Pichard AD; Lindsay J; Waksman R
Arch Cardiovasc Dis; 2009 Mar; 102(3):209-17. PubMed ID: 19375675
[TBL] [Abstract][Full Text] [Related]
11. Percutaneous coronary intervention for a right coronary artery stent occlusion using retrograde delivery of a sirolimus-eluting stent via a septal perforator.
Utunomiya M; Katoh O; Nakamura S
Catheter Cardiovasc Interv; 2009 Mar; 73(4):475-80. PubMed ID: 19229979
[TBL] [Abstract][Full Text] [Related]
12. Impact of post-intervention minimal stent area on 9-month follow-up patency of paclitaxel-eluting stents: an integrated intravascular ultrasound analysis from the TAXUS IV, V, and VI and TAXUS ATLAS Workhorse, Long Lesion, and Direct Stent Trials.
Doi H; Maehara A; Mintz GS; Yu A; Wang H; Mandinov L; Popma JJ; Ellis SG; Grube E; Dawkins KD; Weissman NJ; Turco MA; Ormiston JA; Stone GW
JACC Cardiovasc Interv; 2009 Dec; 2(12):1269-75. PubMed ID: 20129555
[TBL] [Abstract][Full Text] [Related]
13. Pathology of drug-eluting versus bare-metal stents in saphenous vein bypass graft lesions.
Yazdani SK; Farb A; Nakano M; Vorpahl M; Ladich E; Finn AV; Kolodgie FD; Virmani R
JACC Cardiovasc Interv; 2012 Jun; 5(6):666-74. PubMed ID: 22721663
[TBL] [Abstract][Full Text] [Related]
14. Distal embolization after net protective stent (MGUARD) implantation in a degenerated saphenous vein graft lesion.
Yassin I; Thuesen L
Catheter Cardiovasc Interv; 2010 Mar; 75(4):639-41. PubMed ID: 20091812
[TBL] [Abstract][Full Text] [Related]
15. Five-year clinical outcomes after coronary stenting of chronic total occlusion using sirolimus-eluting stents: insights from the rapamycin-eluting stent evaluated at Rotterdam Cardiology Hospital-(Research) Registry.
Shen ZJ; García-García HM; Garg S; Onuma Y; Schenkeveld L; van Domburg RT; Serruys PW;
Catheter Cardiovasc Interv; 2009 Dec; 74(7):979-86. PubMed ID: 19753636
[TBL] [Abstract][Full Text] [Related]
16. Recent progress in percutaneous coronary intervention: evolution of the drug-eluting stents, focus on the XIENCE V drug-eluting stent.
Doostzadeh J; Clark LN; Bezenek S; Pierson W; Sood PR; Sudhir K
Coron Artery Dis; 2010 Jan; 21(1):46-56. PubMed ID: 19952925
[TBL] [Abstract][Full Text] [Related]
17. Are our patients better off with drug-eluting stents in saphenous vein grafts?
Douglas JS
JACC Cardiovasc Interv; 2009 Nov; 2(11):1113-5. PubMed ID: 19926053
[No Abstract] [Full Text] [Related]
18. 3-year follow-up of the SISR (Sirolimus-Eluting Stents Versus Vascular Brachytherapy for In-Stent Restenosis) trial.
Holmes DR; Teirstein PS; Satler L; Sketch MH; Popma JJ; Mauri L; Wang HP; Schleckser PA; Cohen SA;
JACC Cardiovasc Interv; 2008 Aug; 1(4):439-48. PubMed ID: 19463342
[TBL] [Abstract][Full Text] [Related]
19. Importance of creativity: new applications of the Proxis catheter.
Satler LF
Catheter Cardiovasc Interv; 2009 Sep; 74(3):446-7. PubMed ID: 19681123
[No Abstract] [Full Text] [Related]
20. Drug-eluting stents versus bare-metal stents in saphenous vein graft interventions.
Rozenman Y
JACC Cardiovasc Interv; 2011 May; 4(5):590-1; author reply 591-3. PubMed ID: 21596337
[No Abstract] [Full Text] [Related]
[Next] [New Search]